Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study

1. Usmani, S.Z.
2. Garfall, A.L.
3. van de Donk, N.W.C.J.
4. Nahi, H.
5. San-Miguel, J.F.
6. Oriol, A.
7. Rosinol, L.
8. Chari, A.
9. Bhutani, M.
10. Karlin, L.
11. Benboubker, L.
12. Pei, L.
13. Verona, R.
14. Girgis, S.
15. Stephenson, T.
16. Elsayed, Y.
17. Infante, J.
18. Goldberg, J.D.
19. Banerjee, A.
20. Mateos, M.-V.
21. Krishnan, A.